- Vouliez-vous dire
- policy
Résultats de la recherche - 5 results
Assessment of the clinical and analytical performance of three Seegene Allplex SARS-CoV-2 assays within the VALCOR framework.
SARS-CoV-2 dissemination across borders using population and wastewater surveillance. The anticipation by WHO and central health care policy entities such as the Center for Disease Control, EMA, and multiple ...
Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV.
Women living with HIV have 6-times the risk of cervical cancer compared to women in the general population, and we harnessed a model platform (‘Policy1-Cervix- HIV ’) to evaluate the benefits and harms of ...
Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population.
published updated cervical screening guidelines in 2021. To inform this update, we used an established modeling platform, Policy1-Cervix, to evaluate the impact of seven primary screening scenarios across 78 ...
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
Michal F; M. Arbyn; Nowakowski, Andrzej Source: BMC Cancer, Volume 23, Issue 1 (2023) Keywords: Atypical Squamous Cells of the Cervix Colposcopy Early Detection of Cancer Female HEALTH POLICY Humans Mass ...
IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues.
Unger, Elizabeth R; IPVS Policy Committee Source: J Clin Virol, Volume 159 (2023) Keywords: Early Detection of Cancer Female Humans Mass Screening nucleic acids Papillomaviridae Papillomavirus Infections ...